Advanced search
Publication Cover
Nanomedicine Volume 6, 2011 - Issue 3
Submit an article Journal homepage
479
Views
1
CrossRef citations to date
0
Altmetric
Review

Magnetoliposomes as Multimodal Contrast Agents for Molecular Imaging and Cancer Nanotheragnostics

Hassan Fattahi1 Department of General, Organic & Biomedical Chemistry, NMR & Molecular Imaging Laboratory, University of Mons, Avenue Maistriau, 19, B-7000 Mons, Belgium. [email protected];2 Polymer research laboratory, Department of Organic & Biochemistry, Faculty of Chemistry, University of Tabriz, 29 Bahman Blvd, Tabriz, IranView further author information
,
Sophie Laurent1 Department of General, Organic & Biomedical Chemistry, NMR & Molecular Imaging Laboratory, University of Mons, Avenue Maistriau, 19, B-7000 Mons, Belgium. [email protected]View further author information
,
Fujun Liu1 Department of General, Organic & Biomedical Chemistry, NMR & Molecular Imaging Laboratory, University of Mons, Avenue Maistriau, 19, B-7000 Mons, Belgium. [email protected]View further author information
,
Nasser Arsalani2 Polymer research laboratory, Department of Organic & Biochemistry, Faculty of Chemistry, University of Tabriz, 29 Bahman Blvd, Tabriz, IranView further author information
,
Luce Vander Elst1 Department of General, Organic & Biomedical Chemistry, NMR & Molecular Imaging Laboratory, University of Mons, Avenue Maistriau, 19, B-7000 Mons, Belgium. [email protected]View further author information
&
Robert N Muller1 Department of General, Organic & Biomedical Chemistry, NMR & Molecular Imaging Laboratory, University of Mons, Avenue Maistriau, 19, B-7000 Mons, Belgium. [email protected]Correspondence[email protected]
View further author information
Pages 529-544 | Published online: 04 May 2011

Bibliography

  • Molecular Imaging: Principals and Practice. Weissleder R, Ross BD, Rehemetulla A, Gambhir SG (Eds). People‘s Medical Publishing House, USA (2010).
  • Zarbin MA , MontemagnoC, LearyJF, RitchR: Nanomedicine in ophthalmology: the new frontier.Am J. Ophthalmol.150, 144–162 (2010).
  • Buxton DB : Nanomedicine for the management of lung and blood diseases.Nanomedicine (Lond.)4, 331–339 (2009).
  • Godin B , SakamotoJH, SerdaREet al.: Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.Trends Pharmacol. Sci.31, 199–205 (2010).
  • McCarron PA , FaheemAM: Nanomedicine-based cancer targeting: a new weapon in an old war.Nanomedicine (Lond).5, 3–5 (2010).
  • Laurent S , ForgeD, PortMet al.: Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.Chem. Rev.108, 2064–2110 (2008).
  • Bulte JWM , KraitchmanDL: Iron oxide MR contrast agents for molecular and cellular imaging.NMR Biomed.17, 484–499 (2004).
  • Terreno E , CastelliDD, VialeAet al.: Challenges for molecular magnetic resonance imaging.Chem. Rev.110, 3019–3042 (2010).
  • Gupta AK , GuptaM: Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.Biomaterials26, 3995–4021 (2005).
  • Zhang L , XueH, GaoCet al.: Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3,4-dihydroxyphenyl-L-alanine linkages.Biomaterials31, 6582–6588 (2010).
  • Bulte JWM , DouglasT, WitwerBet al.: Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells.Nat. Biotechnol.19, 1141–1147 (2001).
  • Soenen SJH , HodeniusM, Schmitz-RodeT, De Cuyper M: Protein-stabilized magnetic fluids. J. Magn. Magn. Mater.320, 32–39 (2008).
  • De Cuyper M , HodeniusM, IvanovaGet al.: Specific heating power of fatty acid and phospholipid stabilized magnetic fluids in an alternating magnetic field.J. Phys. Cond. Matter.20, 204131.1–204131.5 (2008).
  • Mulder WJM , StrijkersGJ, TilborgGAF, GriffioenAW, NicolayK: Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.NMR Biomed.19, 142–164 (2006).
  • De Cuyper M , JoniauM: Magnetoliposomes: formation and structural characterization.Eur. Biophys. J.15, 311–319 (1988).
  • Jiao Y , PengZH, ZhangJY, QinJ, ZhongCP: Liposome-mediated transfer can improve the efficacy of islet labeling with superparamagnetic iron oxide.Transplant. Proc.40, 3615–3618 (2008).
  • Yu Y , AnthonySM, BaeSCet al.: Biomolecular science of liposome–nanoparticle constructs.Mol. Cryst. Liq. Cryst.507, 18–25 (2009).
  • Soenen SJH , HodeniusM, De Cuyper M: Magnetoliposome: innovative nanocolloids for use in biotechnology and biomedicine. Nanomedicine4, 177–191 (2009).
  • Al-Jamal W , KostarelosK: Liposome–nanoparticle hybrids for multimodal diagnostic and therapeutic applications.Nanomedicine (Lond).2, 85–98 (2007).
  • Torchilin VP : Recent approaches to intracellular delivery of drugs and DNA and onganelle targeting.Annu. Rev. Biomed. Eng.8, 343–375 (2006).
  • Lawrence MJ , ReesGD: Microemulsion-based media as novel drug delivery systems.Adv. Drug Deliv. Rev.45, 89–121 (2000).
  • Torchilin VP : PEG-based micelles as carriers of contrast agents for different imaging modalities.Adv. Drug Deliv. Rev.54, 235–252 (2002).
  • Torchilin VP : Surface-modified liposomes in γ- and MR-imaging.Adv. Drug Deliv. Rev.24, 301–313 (1997).
  • Margolis LB , NamiotVA, KljukinLM: Magnetoliposomes: another principle of cell sorting.Biochim. Biophys. Acta735, 193–195 (1983).
  • Sahoo Y , PizemH, FriedTet al.: Alkyl phosphonate/phosphate coating on magnetite nanoparticles: a comparison with fatty acids.Langmuir17, 7907–7911 (2001).
  • De Cuyper M , CaluwierD, BaertJ, CocquytJ, Van der Meeren P: A successful strategy for the production of cationic magnetoliposomes. Z. Phys. Chem.220, 133–141 (2006).
  • Soenen SJH , BaertJ, De Cuyper M: Optimal conditions for labeling of 3T3 fibroblasts with magnetoliposomes without affecting cellular viability. ChemBioChem8, 2067–2077 (2007).
  • Martina MS , FortinJP, MenagerCet al.: Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging.J. Am. Chem. Soc.127, 10676–10685 (2005).
  • Sabate R , Barnadas-RodriguezR, Callejas-FernandezJ, Hidalgo-AlvarezR, EstelrichJ: Preparation and characterization of extruded magnetoliposomes.Int. J. Pharm.347, 156–162 (2008).
  • Janib SM , MosesAS, MacKayJA: Imaging and drug delivery using theranostic nanoparticles.Adv. Drug Del. Rev.62, 1052–1063 (2010).
  • Fang C , ZhangM: Nanoparticle-based theragnostics: integrating diagnostic and therapeutic potentials in nanomedicine.J. Control. Release89, 47–55 (2010).
  • Chen Y , BoseA, BothunGD: Controlled release from bilayer decorated magnetoliposomes via electromagnetic heating.ACS Nano.4, 3215–3221 (2010).
  • Rinck PA : Magnetic Resonance in Medicine. Wiley-Blackwell, Berlin, Germany (2003).
  • Laurent S , Vander Elst L, Roch A, Muller RN: Structure, synthesis and characterization of contrast agents for magnetic resonance molecular imaging. In: NMR-MRI, µSR and Mössbauer Spectroscopies in Molecular Magnets. Carretta P, Lascialfari A (Eds). Springer, Milano, Italy, 71–87 (2007).
  • Geraldes CFGC , LaurentS: Classification and basic properties of contrast agents for magnetic resonance imaging.Contrast Med. Mol. Imaging4, 1–23 (2009).
  • The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. Merbach AE, Toth E (Eds). John Wiley, England, UK (2001).
  • Waters EA , WicklineSA: Contrast agents for MRI.Basic Res. Cardiol.103, 114–121 (2008).
  • Yan G-P , Robinson L, Hogg P: Magnetic resonance imaging contrast agents: overview and perspectives. Radiography13, E5–E19 (2007).
  • Terreno E , Delli Castelli D, Aime S: Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol. Imaging5, 78–98 (2010).
  • Viswanathan S , KovacsZ, RatnakarSJ, GreenKN, SherryAD: Alternatives to gadolinium-based metal chelates for magnetic resonance imaging.Chem. Rev.110, 2960–3018 (2010).
  • Taboada E , RodriguezE, RoigA, OroJ, RochA, MullerRN: Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.Langmuir23, 4583–4588 (2007).
  • Stuber M , GilsonWD, SchärMet al.: Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON).Magnet. Reson. Med.58, 1072–1077 (2007).
  • Senpan A , CaruthersSD, RheeIet al.: Conquering the dark side: colloidal iron oxide nanoparticles.ACS Nano.3, 3917–3926 (2009).
  • Mornet S , PortierJ, DoguetE: A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran.J. Magn. Magn. Mater.293, 127–134 (2005).
  • Mornet S , VasseurS, GrassetF, GuguetE: Magnetic nanoparticle design for medical diagnosis and therapy.J. Mater. Chem.14, 2161–2175 (2004).
  • Arbab AS , BashawLA, MillerBRet al.: Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.Radiology229, 838–846 (2003).
  • Bulte JW , De Cuyper M: Magnetoliposomes as contrast agents. Methods Enzymol.373, 175–198 (2003).
  • Yang C , RaitA, PirolloKFet al.: Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo.Nanomedicine4, 318–329 (2008).
  • Fortin-Ripoche J-P , Martina MS, Gazeau F et al.: Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. Radiology239, 415–424 (2006).
  • Bulte JWM , De Cuyper M, Despres D, Frank JA: Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent. J. Magn. Magn. Mater.194, 204–209 (1999).
  • De Cuyper M , SoenenSJH, CoenegrachtsK, BeekL T: Surface functionalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: anchoring of gadolinium ions to a lipophilic chelate. Anal. Biochem.367, 266–273 (2007).
  • Soenen SJH , DesenderL, De Cuyper M: Complexation of gadolinium(III) ions on top of nanometer-sized magnetoliposomes. Int. J. Environ. An. Ch.87, 783–796 (2007).
  • Zaidi H , PrasadR: Advances in multimodality molecular imaging.J. Med. Phys.34, 122–128 (2009).
  • Weissleder R , PittetMJ: Imaging in the era of molecular oncology.Nature452, 580–589 (2008).
  • Soenen SJH , VercauterenD, BraeckmansK, NoppeW, De Smedt S, De Cuyper M: Stable long-term intracellular labelling with fluorescently tagged cationic magnetoliposomes. ChemBioChem10, 257–267 (2009).
  • Van Tilborg GA , MulderWJ, DeckersNet al.: Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis.Bioconjug. Chem.17, 741–749 (2006).
  • Plassat V , MartinaMS, BarrattG, MenagerC, LesieurS: Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution.Int. J. Pharm.344, 118–127 (2007).
  • Martina MS , WilhelmC, LesieurS: The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells.Biomaterials29, 4137–4145 (2008).
  • Fang C , ZhangM: Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine.J. Control. Release146, 2–5 (2010).
  • Ozdemir V , Williams-JonesB, GlattSJet al.: Shifting emphasis from pharmacogenomics to theragnostics.Nat. Biotechnol.24, 942–946 (2006).
  • Maeng JH , Lee D-H, Jung KH et al.: Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials31, 4995–5006 (2010).
  • Weissleder R : Molecular imaging in cancer.Science312, 1168–1171 (2006).
  • Kim K , KimJH, ParkHet al.: Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring.J. Control. Release146, 219–227 (2010).
  • Veiseh O , GunnJW, ZhangM: Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.Adv. Drug Del. Rev.62, 284–304 (2010).
  • Torchilin V : Multifunctional and stimuli-sensitive pharmaceutical nanocarriers,Eur. J. Pherm. Biopharm.71, 431–444 (2009).
  • Bharali DJ , MousaSA: Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.Pharmacol. Therapeut.128, 324–335 (2010).
  • Shubayev VI , PisanicTR, JinS: Magnetic nanoparticles for theragnostics.Adv. Drug Del. Rev.61, 467–477 (2010).
  • Pradhan P , GiriJ, BanerjeeR, BellareaJ, BahadurD: Preparation and characterization of manganese ferrite-based magnetic liposomes for hyperthermia treatment of cancer.J. Magn. Magn. Mater.311, 208–215 (2007).
  • Soenen SJH , CocquytJ, DefourL, SaveynP, Van der Meeren, De Cuyper M: Design and development of magnetoliposome-based theragnostics. Mater. Manuf. Process.23, 611–614 (2008).
  • Wang M , ThanouM: Targeting nanoparticles to cancer.Pharmacol. Res.62, 90–99 (2010).
  • McCarthy JR , WeisslederR: Multifunctional magnetic nanoparticles for targeted imaging and therapy,Adv. Drug Del. Rev.60, 1241–1251 (2008).
  • Tai LA , TsaiPJ, WangYCet al.: Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release.Nanotechnology20, 135101–135110 (2009).
  • Chen Y , BoseA, BothunGD: Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating.ACS Nano.4, 3215–3221 (2010).
  • Pradhan P , GiriJ, RiekenFet al.: Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.J. Control. Release142, 108–121 (2010).
  • Jain TK , RicheyJ, StrandM, DimitrijevicS, FlaskCA, LabhasetwarV: Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging.Biomaterials29, 4012–4021 (2008).
  • Jain TK , FoySP, ErokwuB, DimitrijevicS, FlaskCA, LabhasetwarV: Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice.Biomaterials30, 6748–6756 (2009).
  • Lee H , YuMK, ParkSet al.: Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.J. Am. Chem. Soc.129, 12739–12745 (2007).
  • Yu MK , JeongYY, ParkJet al.: Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.Angew. Chem. Int. Ed.47, 5362–5365 (2008).
  • Sahiner N , IlginP: Multiresponsive polymeric particles with tunable morphology and properties based on acrylonitrile (AN) and 4-vinylpyridine (4-VP).Polymer51, 3156–3163 (2010).
  • Huh MS , Lee S-Y, Park S et al.: Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J. Control. Release144, 134–143 (2010).
  • Kim K , KimJH, ParkHet al.: Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring.J. Control. Release146, 219–227 (2010).
  • Yang X , GrailerJJ, RowlandIJet al.: Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging.Biomaterials31, 9065–9073 (2010).
  • Nanotoxicity: From In Vivo and In Vitro Models to Health Risks. Sahu SC, Casciano DA (Eds). John Wiley, UK (2009).
  • Soenen SJH , De Cuyper M: Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol. Imaging4, 207–219 (2009).
  • Garcia VAP , LacavaLM, KuckelhausSet al.: Magnetoliposome evaluation using cytometry and micronucleus test.Eur. Cells Mater.3, 154–155 (2002).
  • Lacava ZGM , GarciaVAP, LacavaLMet al.: Biodistribution and biocompatibility investigation in magnetoliposome treated mice.Spectroscopy18, 597–603 (2004).
  • Lv H , ZhangS, WangB, CuiS, YanJ: Toxicity of cationic lipids and cationic polymers in gene delivery.J. Control. Release114, 100–109 (2006).
  • Soenen SJH , HimmelreichU, NuyttenN, PisanicTR, FerrariA, De Cuyper M: Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small6, 2136–2145 (2010).
  • Slotkin JR , CahillKS, TharinSA, ShapiroEM: Cellular magnetic resonance imaging: nanometer and micrometer size particles for noninvasive cell localization.Neurotherapeutics4, 428–433 (2007).
  • Li P , LiD, ZhangL, LiG, WangE: Cationic lipid bilayer coated gold nanoparticle-mediated transfection of mammalian cells.Biomaterials29, 3617–3624 (2008).
  • Soenen SJH , BrissonA, De Cuyper M: Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials30, 3691–701 (2009)
  • Soenen SJ , IllyesE, VercauterenDet al.: The role of nanoparticle concentration-dependent induction of cellular stress in the internalization of non-toxic cationic magnetoliposomes.Biomaterials30, 6803–6813 (2009).
  • Soenen SJH , HimmelreichU, NuyttenN, De Cuyper M: Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labeling. Biomaterials32, 195–205 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.